These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 21658644)
1. Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). De Boeck K; Bulteel V; Tiddens H; Wagner T; Fajac I; Conway S; Dufour F; Smyth AR; Lee T; Sermet I; Kassai B; Elborn S; J Cyst Fibros; 2011 Jun; 10 Suppl 2():S67-74. PubMed ID: 21658644 [TBL] [Abstract][Full Text] [Related]
2. Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis? Matecki S; Kent L; de Boeck K; Le Bourgeois M; Zielen S; Braggion C; Arets HG; Bradley J; Davis S; Sermet I; Reix P; J Cyst Fibros; 2016 Jan; 15(1):10-20. PubMed ID: 25890589 [TBL] [Abstract][Full Text] [Related]
3. Disease-specific clinical trials networks: the example of cystic fibrosis. De Boeck K; Bulteel V; Fajac I Eur J Pediatr; 2016 Jun; 175(6):817-24. PubMed ID: 26979528 [TBL] [Abstract][Full Text] [Related]
4. Measuring health-related quality of life in clinical trials in cystic fibrosis. Abbott J; Hart A; Havermans T; Matossian A; Goldbeck L; Barreto C; Bergsten-Brucefors A; Besier T; Catastini P; Lupi F; Staab D J Cyst Fibros; 2011 Jun; 10 Suppl 2():S82-5. PubMed ID: 21658648 [TBL] [Abstract][Full Text] [Related]
5. Clinical trials in cystic fibrosis. Döring G; Elborn JS; Johannesson M; de Jonge H; Griese M; Smyth A; Heijerman H; J Cyst Fibros; 2007 Apr; 6(2):85-99. PubMed ID: 17350898 [TBL] [Abstract][Full Text] [Related]
6. The implementation of standards of care in Europe: state of the art. Colombo C; Littlewood J J Cyst Fibros; 2011 Jun; 10 Suppl 2():S7-15. PubMed ID: 21658645 [TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
8. European cystic fibrosis society consensus on standards--a roadmap to "best care". Littlewood JM J Cyst Fibros; 2005 Mar; 4(1):1-5. PubMed ID: 15752676 [No Abstract] [Full Text] [Related]
9. [The Coordinating Centers for Clinical Trials (KKS) and the KKS Network: competence for clinical research]. Ohmann C; Bruns I; Wolff S Onkologie; 2010; 33 Suppl 7():11-5. PubMed ID: 20926908 [TBL] [Abstract][Full Text] [Related]
10. E-learning within the European cystic fibrosis society - A multidisciplinary cross-sectional survey. Smith C; Chadwick HK; Hill K; Peckham DG; J Cyst Fibros; 2024 Sep; 23(5):1020-1023. PubMed ID: 38997825 [TBL] [Abstract][Full Text] [Related]
11. Medical consensus, guidelines, and position papers: a policy for the ECFS. De Boeck K; Castellani C; Elborn JS; J Cyst Fibros; 2014 Sep; 13(5):495-8. PubMed ID: 25053447 [TBL] [Abstract][Full Text] [Related]
12. Controlled clinical trials in cystic fibrosis--are we doing better? Briggs TA; Bryant M; Smyth RL J Cyst Fibros; 2006 Jan; 5(1):3-8. PubMed ID: 16271521 [TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites. Zon R; Meropol NJ; Catalano RB; Schilsky RL J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967 [TBL] [Abstract][Full Text] [Related]
14. "Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspective. Coucke R; Chansard A; Bontemps V; Grenet D; Hubert D; Martin C; Lammertyn E; Bardin E; Bulteel V; Chedevergne F; Bourgeois ML; Burgel PR; Honore I; de Keyser H; Kirszenbaum M; de Carli P; Sermet-Gaudelus I; Hayes K; J Cyst Fibros; 2021 Nov; 20(6):e108-e113. PubMed ID: 33648900 [TBL] [Abstract][Full Text] [Related]
15. [Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use]. Schöni-Affolter F; Oswald P; Wandt-Baumann C; Kriemler S; Schöni MH Schweiz Med Wochenschr; 2000 Sep; 130(39):1373-81. PubMed ID: 11059028 [TBL] [Abstract][Full Text] [Related]
16. Developing new products in cystic fibrosis: needs and obstacles for activities of small and middle-sized companies. Schlangen M; Reimann AL J Cyst Fibros; 2011 Jun; 10 Suppl 2():S103-9. PubMed ID: 21658629 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. Bilton D; Canny G; Conway S; Dumcius S; Hjelte L; Proesmans M; Tümmler B; Vavrova V; De Boeck K J Cyst Fibros; 2011 Jun; 10 Suppl 2():S79-81. PubMed ID: 21658647 [TBL] [Abstract][Full Text] [Related]
19. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases. Goss CH; Mayer-Hamblett N; Kronmal RA; Ramsey BW Adv Drug Deliv Rev; 2002 Dec; 54(11):1505-28. PubMed ID: 12458158 [TBL] [Abstract][Full Text] [Related]